These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Renin-angiotensin-aldosterone system peptide profiles in patients with COVID-19. Kutz A; Conen A; Gregoriano C; Haubitz S; Koch D; Domenig O; Bernasconi L; Mueller B; Schuetz P Eur J Endocrinol; 2021 Apr; 184(4):543-552. PubMed ID: 33539316 [TBL] [Abstract][Full Text] [Related]
4. Does Angiotensin II Peak in Response to SARS-CoV-2? Xavier LL; Neves PFR; Paz LV; Neves LT; Bagatini PB; Timmers LFSM; Rasia-Filho AA; Mestriner RG; Wieck A Front Immunol; 2020; 11():577875. PubMed ID: 33519802 [TBL] [Abstract][Full Text] [Related]
5. Mechanical dependency of the SARS-CoV-2 virus and the renin-angiotensin-aldosterone (RAAS) axis: a possible new threat. Sen R; Sengupta D; Mukherjee A Environ Sci Pollut Res Int; 2022 Sep; 29(41):62235-62247. PubMed ID: 34859345 [TBL] [Abstract][Full Text] [Related]
6. Endocrine aspects of ACE2 regulation: RAAS, steroid hormones and SARS-CoV-2. Young MJ; Clyne CD; Chapman KE J Endocrinol; 2020 Nov; 247(2):R45-R62. PubMed ID: 32966970 [TBL] [Abstract][Full Text] [Related]
7. The Renin-Angiotensin-Aldosterone System and Coronavirus Disease 2019. Coto E; Avanzas P; Gómez J Eur Cardiol; 2021 Feb; 16():e07. PubMed ID: 33737961 [TBL] [Abstract][Full Text] [Related]
8. Association of Renin-Angiotensin-Aldosterone Inhibitors with COVID-19 Infection and Disease Severity among Individuals with Hypertension. Mahanaimy M; Finkel U; Barda N; Rottman E; Balicer R; Berliner Senderey A; Feldman B Isr Med Assoc J; 2022 May; 24(5):310-316. PubMed ID: 35598055 [TBL] [Abstract][Full Text] [Related]
9. Risk of SARS-CoV-2 infection and COVID-19 prognosis with the use of renin-angiotensin-aldosterone system (RAAS) inhibitors: a systematic review. Iheanacho CO; Odili VU; Eze UIH Futur J Pharm Sci; 2021; 7(1):73. PubMed ID: 33778087 [TBL] [Abstract][Full Text] [Related]
10. Spironolactone may provide protection from SARS-CoV-2: Targeting androgens, angiotensin converting enzyme 2 (ACE2), and renin-angiotensin-aldosterone system (RAAS). Cadegiani FA; Goren A; Wambier CG Med Hypotheses; 2020 Oct; 143():110112. PubMed ID: 32721806 [TBL] [Abstract][Full Text] [Related]
11. Beauty and the beast: host microRNA-155 versus SARS-CoV-2. Papadopoulos KI; Papadopoulou A; Aw TC Hum Cell; 2023 May; 36(3):908-922. PubMed ID: 36847920 [TBL] [Abstract][Full Text] [Related]
12. The Role of Renin-Angiotensin-Aldosterone System in the Heart and Lung: Focus on COVID-19. Mascolo A; Scavone C; Rafaniello C; De Angelis A; Urbanek K; di Mauro G; Cappetta D; Berrino L; Rossi F; Capuano A Front Pharmacol; 2021; 12():667254. PubMed ID: 33959029 [TBL] [Abstract][Full Text] [Related]
13. A Subpopulation of Foxj1-Expressing, Nonmyelinating Schwann Cells of the Peripheral Nervous System Contribute to Schwann Cell Remyelination in the Central Nervous System. Ma D; Wang B; Zawadzka M; Gonzalez G; Wu Z; Yu B; Rawlins EL; Franklin RJM; Zhao C J Neurosci; 2018 Oct; 38(43):9228-9239. PubMed ID: 30228229 [TBL] [Abstract][Full Text] [Related]
15. Renin-Angiotensin Aldosterone System Inhibitors and COVID-19: A Systematic Review and Meta-Analysis Revealing Critical Bias Across a Body of Observational Research. Loader J; Taylor FC; Lampa E; Sundström J J Am Heart Assoc; 2022 Jun; 11(11):e025289. PubMed ID: 35624081 [TBL] [Abstract][Full Text] [Related]
16. Increased complications of COVID-19 in people with cardiovascular disease: Role of the renin-angiotensin-aldosterone system (RAAS) dysregulation. Augustine R; S A; Nayeem A; Salam SA; Augustine P; Dan P; Maureira P; Mraiche F; Gentile C; Hansbro PM; McClements L; Hasan A Chem Biol Interact; 2022 Jan; 351():109738. PubMed ID: 34740598 [TBL] [Abstract][Full Text] [Related]
17. Brain Renin-Angiotensin System: From Physiology to Pathology in Neuronal Complications Induced by SARS-CoV-2. Ahmadi S; Khaledi S Anal Cell Pathol (Amst); 2023; 2023():8883492. PubMed ID: 37575318 [TBL] [Abstract][Full Text] [Related]
18. Serum ACE2, Angiotensin II, and Aldosterone Levels Are Unchanged in Patients With COVID-19. Rieder M; Wirth L; Pollmeier L; Jeserich M; Goller I; Baldus N; Schmid B; Busch HJ; Hofmann M; Kern W; Bode C; Duerschmied D; Lother A Am J Hypertens; 2021 Apr; 34(3):278-281. PubMed ID: 33043967 [TBL] [Abstract][Full Text] [Related]
19. Controversial Roles of the Renin Angiotensin System and Its Modulators During the COVID-19 Pandemic. Gressens SB; Leftheriotis G; Dussaule JC; Flamant M; Levy BI; Vidal-Petiot E Front Physiol; 2021; 12():624052. PubMed ID: 33692701 [TBL] [Abstract][Full Text] [Related]
20. Is the prognosis of non-hypertensive, COVID-19 patients treated with renin-angiotensin-aldosterone system inhibitors more uncertain? García Martínez JJ; Wozniak H; Salamin P; Giraud R; Le Terrier C; Bendjelid K Physiol Rep; 2022 Nov; 10(22):e15512. PubMed ID: 36397298 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]